University of Washington School of Medicine
"We are very excited that the University of Washington Hematology-Focused Fellowship Training Program (HFFTP) will train the next generation of leaders in the field of blood disorders. At the University of Washington and Fred Hutchinson Cancer Center, the breadth and depth of our malignant and non-malignant hematology expertise will provide hematology-focused fellows not only superb clinical training but also a diverse group of potential mentors. Faculty from our 4 hematology-focused pathways (Hemostasis/thrombosis, Marrow Failure, Transfusion Medicine, and Systems-based Hematology), along with the robust infrastructure and history of cross-specialty collaboration at our large institution, will afford fellows the opportunity to pursue advanced coursework, bench science, clinical trials, outcomes research, leadership development and skill-building in medical education."
David Garcia, MD, ASH HFFTP Associate Program Director
Contact: [email protected]
"The University of Washington Division of Hematology is thrilled to participate with the American Society of Hematology (ASH) in their Hematology-Focused Fellowship Training Program (HFFTP). The HFFTP is a groundbreaking initiative developed by ASH to address recruitment, retention and workforce needs in non-malignant hematology. HFFTP awards were granted to established programs with strong track records and innovative proposals for didactic, experiential, scholarly and research training pathways. ASH funds 3 years of training for one additional fellow per year over the course of five years. Our UW HFFTP pathways offer unique curriculum elements, interdisciplinary clinical activities and creative training opportunities in four focus areas. These include: hemostasis & thrombosis; transfusion medicine and cellular therapies; marrow failure syndromes; and systems-based hematology. Fellows in the transfusion medicine pathway may elect to pursue a full 1-year ACGME-accredited transfusion medicine fellowship during their training. All HFFTP fellows will complete requirements for ABIM certification."
Mike Linenberger, MD, ASH HFFTP Program Director
Contact: [email protected]
With the addition of the 4 scholarly pathways that we have created for the HFFTP, the clinical, research and scholarly opportunities available to traditional hematology/oncology fellows will be expanded. Our fellowship program is already approved by ACGME for nine fellows per year. The HFFTP fellow will represent a ninth trainee.
HFFTP clinical assignments will be made to: (a) rotation sites that either do not currently have a fellow every month or can substitute the HFFTP fellow for a traditional fellow; (b) a new, elective rotation specifically designed for the HFFTP fellow; or (c) an existing rotation that currently utilizes a monthly, fulltime clinical fellow(s), where the HFFTP fellow will be added. This last case will occur on two rotations: Harborview Medical Center (HMC) and the VA. For each of these rotations, the roles and responsibilities of the HFFTP fellow will be differentiated from those of the traditional fellow(s). For example, currently, a single fellow serves as the sole consultant every month at HMC, which is a large, county hospital with very active, high-volume outpatient clinics and inpatient medical, surgical, psychiatric and OB/Gyn services. For the HFFTP fellow’s HMC rotation, they will be paired with a traditional fellow who will primarily see medical oncology patients while the HFFTP fellow will primarily see patients with non-malignant and malignant hematologic disorders. A similar structure will be used for the HFFTP fellow during their rotations at the VA, where we currently have 2 rotating fellows per month.
Pathways in our HFFTP address existing unmet needs and future opportunities in academic medicine, research, health systems and education. Our HFFTP fellows work closely with senior hematology preceptors, cross-disciplinary faculty, colleagues at externship sites and research mentors. Fellows may pursue advanced coursework, bench science, clinical trials, outcomes research, leadership development and skill-building in medical education. Our HFFTP pathways will also enrich the experiences of fellows in our traditional hematology training tracks. We anticipate that our HFFTP graduates will be future leaders in patient care, education, research, systems-based and multi-disciplinary hematology with tremendous potential to positively impact community practice through outreach, collaboration and networking.
Lastly, we will have the capacity for an HFFTP fellow with a career focus in transfusion medicine/cellular therapies to pursue a full 1-year Transfusion Medicine (TM) fellowship during their 3rd year in the program. This experience will be administered through a collaborative agreement with the UW Pathology Department’s ACGME-accredited TM fellowship program and will be funded by our HFFTP. The HFFTP fellow will, therefore, be eligible for board-certification in both hematology and transfusion medicine.